FISHER & PAYKEL HEALTHCARE TO ANNOUNCE ITS FISCAL 2003 FULL YEAR RESULTS ON 22 MAY 2003
Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH. ASX:FPH) ), announced today that it intends to release on Thursday 22 May 2003 its fiscal 2003 full year results for the period ended 31 March 2003. The results release will be issued shortly after 8.30am NZT, 6.30am AEST (4.30pm, Wednesday 21 May 2003 USEST).
Fisher & Paykel Healthcare will host a conference call to review the results and to discuss the outlook for fiscal year 2004. The conference call will be broadcast simultaneously over the Internet.
To listen to the webcast, to be held at 9.30am NZT, 7.30am AEST on Thursday 22 May (5.30pm USEST, Wednesday 21 May), access the company’s website at www.fphcare.com . Please allow extra time prior to the webcast to visit the site and download the streaming media software required. An online archive of the event will be available approximately two hours after the webcast and will remain onsite for approximately two weeks.
For those people unable to access the call via the Internet, we are making available an audio replay of the conference call. This will be available from approximately 11.30am NZT for two weeks. To listen to the replay dial +61 2 8524 1009 international or 02 8524 1009 within Australia. The passcode to access the recording is 125008#.
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of heated humidification products and systems for use in respiratory care and the treatment of obstructive sleep apnea. It also offers an innovative range of patient warming devices and neonatal care products. The company’s products are sold in over 90 countries worldwide.
Further information can be obtained by contacting Michael Daniell on +64 9 574 0161 or Tony Barclay on +64 9 574 0119 at Fisher & Paykel Healthcare Corporation Limited or by visiting the company’s website at www.fphcare.com
Fisher & Paykel Healthcare to announce its Fiscal 2003 full year results
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Providing Optimal Humidity for intubated patients
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment